The European Conference on Contrast Agent Science will take place in Mons, Belgium, from 19 to 21 May 2010.
The European Conference on Contrast Agent Science will take place in Mons, Belgium, from 19 to 21 May 2010.
Since 1988, the European MR Forum (EMRF) has arranged a series of biannual conferences focused on recent developments in image contrast enhancement by agents or tracers. The purpose of these meetings is to allow those interested in the field to get together to present their research in a setting that fosters discussion, collaboration, and advancement in the field. From the beginning, this group has been composed of both university scientists and representatives from industry.
The conference is organized on the principle of formal scientific exchange during the academic sessions and informal interaction during the rest of the day. Over the years, this has led to the development of new projects and products, often collaborative ones, between industry and academics or between universities. As always, the traditional mood of friendly and open exchange in Mons between the industrial and academic communities will be preserved.
EMRF's conferences are ongoing projects. Their continuity and success depend not only on the intellectual interest, contribution, and support of academics and commercial researchers in the field, as well as on financial support from the research branches of industry, but they also require the attention and input of scientists, radiologists, trainees, and other researchers who use, and improve, contrast agents of all kinds.
This is the first time since 1988 that EMRF requires abstract submissions. Abstracts should reach the scientific committee by 20 March 2010 (extended deadline). They should be attached to the submitter's conference registration.
For more information, please visit: EMRF Online.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.